lobbying_activities: 1369870

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1369870	d3587940-de01-4048-9f40-e6129ddb2408	Q1	HOLLAND & KNIGHT LLP	18466	SHIRE PHARMACEUTICALS, INC	2013	first_quarter	HCR	Worked with congressional offices on issues regarding the economic and social impact of ADHD and challenges of developing products for rare diseases. Advocated for support of Orphan Drug Tax Credit. Also provided information upon request to U.S. GAO regarding study of drug shortages.	Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2013-04-10T09:29:16.117000-04:00